Kovitz Investment Group Partners, LLC Moderna, Inc. Transaction History
Kovitz Investment Group Partners, LLC
- $28.6 Billion
- Q4 2024
A detailed history of Kovitz Investment Group Partners, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 7,838 shares of MRNA stock, worth $258,575. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,838
Previous 7,838
-0.0%
Holding current value
$258,575
Previous $325,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MRNA
# of Institutions
906Shares Held
246MCall Options Held
18MPut Options Held
21.7M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.33 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.28 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$843 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$580 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$241 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.9B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...